Replies to post #9394 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

Exactly.

[glass_half_full]

True, Q3 starts July 1, but my working assumption is that when they say Q3, we won't see anything until September.

Since their original time frame for '113 to enter the clinic was "summer" (which, true, also includes much of September) I take this as pushing the timeline back a bit. I guess, since Autumn starts on 9/23, it's only the potential for a 1-week delay.

What interests me is that they are officially disclosing this as a "Phase 1/2 trial" -- is this something new from the FDA?